Benefits and Challenges of CDK4/6 Inhibitors

Advanced Practice Providers

View More Breast Cancer Gastrointestinal Cancer Genetics Genitourinary Cancer Gynecologic Cancer Hematology Immuno-Oncology Lung Cancer Nurse Navigation Prevention Supportive Care

Breast Cancer Gastrointestinal Cancer Genetics Genitourinary Cancer Gynecologic Cancer Hematology Immuno-Oncology Lung Cancer Nurse Navigation Prevention Supportive Care

Medical World News

Medical World News Podcasts Videos

Conference Coverage

Conference Listing

Publications CME/CE

Subscribe Partners

CancerNetwork.com
CureToday.com
OncLive.com
TargetedOnc.com
Privacy
Terms & Conditions
Do Not Sell My Information

© 2022 MJH Life Sciences and Oncology Nursing News. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Specialty

Advanced Practice Providers

ClinicalSee All >

Breast Cancer
Gastrointestinal Cancer
Genetics
Genitourinary Cancer
Gynecologic Cancer
Hematology
Immuno-Oncology
Lung Cancer
Nurse Navigation
Prevention
Supportive Care

CancerNetwork.com
CureToday.com
OncLive.com
TargetedOnc.com
Privacy
Terms & Conditions
Do Not Sell My Information

© 2022 MJH Life Sciences^™ and Oncology Nursing News. All rights reserved.

December 12, 2018

Previous Video Next Video

Related Content:

VideosBreast Cancer

Podsada Discusses Biomarker Testing and ADC Therapies in Breast Cancer

Podsada Discusses Biomarker Testing and ADC Therapies in Breast Cancer

Sherry Adkins Talks Primary Care Provider Communication Following CAR T-cell Therapy

Sherry Adkins Talks Primary Care Provider Communication Following CAR T-cell Therapy

Beth Sandy on Incorporating Amivantamab and Mobocertinib into Clinical Practice for Patients With EGFR Exon 20 Insertion NSCLC

Beth Sandy on Incorporating Amivantamab and Mobocertinib into Clinical Practice for Patients With EGFR Exon 20 Insertion NSCLC